z-logo
open-access-imgOpen Access
Maintenance 5-Azactidine May Improve Outcomes after Allogeneic Stem-Cell Transplantation in High-Risk AML and MDS Patients
Author(s) -
Ivetta Danylesko,
Noga ShemTov,
Ronit Yerushalmi,
Ar Nagler,
Avichai Shimoni
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.739
Subject(s) - medicine , transplantation , oncology , myelodysplastic syndromes , cytogenetics , stem cell , gastroenterology , bone marrow , biochemistry , chemistry , chromosome , gene , genetics , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom